Researchers sought to determine the outcomes for patients with multiple myeloma who develop bacterial meningitis.
Circulating tumor cell levels were an independent predictor of progression-free survival and overall survival.
Researchers sought to determine whether ocular toxicity occurred in a significant number of patients with multiple myeloma treated with belantamab mafodotin.
In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation.
Researchers sought to determine the implications of plasma levels of microvesicles in patients with multiple myeloma.